These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5815861)

  • 1. Immunization with live attenuated rubella virus vaccine (HPV-77). Clinical and serological results in children and adolescents in Israel.
    Goldblum N; Swartz TA; Klingberg W; Goldwasser RA; Klingberg MA
    Am J Dis Child; 1969 Aug; 118(2):190-6. PubMed ID: 5815861
    [No Abstract]   [Full Text] [Related]  

  • 2. Rubella vaccine trials in adults and children. Comparison of three attenuated vaccines.
    Dudgeon JA; Marshall WC; Peckham CS
    Am J Dis Child; 1969 Aug; 118(2):237-43. PubMed ID: 4893824
    [No Abstract]   [Full Text] [Related]  

  • 3. Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations.
    Hilleman MR; Buynak EB; Whitman JE; Weibel RW; Stokes J
    Am J Dis Child; 1969 Aug; 118(2):166-71. PubMed ID: 5815860
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine.
    Swartz TA; Klingberg W; Goldwasser RA; Klingberg MA; Goldblum N; Hilleman MR
    Am J Epidemiol; 1971 Sep; 94(3):246-51. PubMed ID: 5093654
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with Cendehill rubella vaccine in mature women.
    Farquhar JD; Corretjer JE
    Am J Dis Child; 1969 Aug; 118(2):266-8. PubMed ID: 4893830
    [No Abstract]   [Full Text] [Related]  

  • 6. Live rubella vaccines in adults and children. HPV-77 and Merck-Benoit strains.
    Weibel RE; Stokes J; Buynak EB; Hilleman MR
    Am J Dis Child; 1969 Aug; 118(2):226-9. PubMed ID: 5815862
    [No Abstract]   [Full Text] [Related]  

  • 7. Attenuated rubella viruses. Laboratory and clinical characteristics.
    Meyer HM; Parkman PD; Hobbins TE; Larson HE; Davis WJ; Simsarian JP; Hopps HE
    Am J Dis Child; 1969 Aug; 118(2):155-65. PubMed ID: 4978508
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient arthritis after rubella vaccination.
    Cooper LZ; Ziring PR; Weiss HJ; Matters BA; Krugman S
    Am J Dis Child; 1969 Aug; 118(2):218-25. PubMed ID: 5794817
    [No Abstract]   [Full Text] [Related]  

  • 9. Live attenuated rubella virus vaccines in young adult women. Trials of Cendehill and HPV-77 DE-5.
    Byrne EB; Ryan JM; Randolph MF; Horstmann DM
    Am J Dis Child; 1969 Aug; 118(2):234-6. PubMed ID: 4183351
    [No Abstract]   [Full Text] [Related]  

  • 10. Live, attenuated rubella-virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J
    N Engl J Med; 1968 Aug; 279(6):300-3. PubMed ID: 4969117
    [No Abstract]   [Full Text] [Related]  

  • 11. Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells.
    Plotkin SA; Farquhar JD; Katz M; Buser F
    Am J Dis Child; 1969 Aug; 118(2):178-85. PubMed ID: 5794813
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccination of infants with HPV-77 vaccine.
    Pavilanis V; Chagnon A; Davignon L; Joncas J
    Am J Dis Child; 1969 Aug; 118(2):247-51. PubMed ID: 4978509
    [No Abstract]   [Full Text] [Related]  

  • 13. An open community trial of live rubella vaccines. Study of vaccine virus transmissibility and antigenic efficacy of three HPV-77 derivatives.
    Veronelli JA
    JAMA; 1970 Sep; 213(11):1829-36. PubMed ID: 4917635
    [No Abstract]   [Full Text] [Related]  

  • 14. Live attenuated rubella virus vaccines prepared in duck embryo cell culture. I. Development and clinical testing.
    Buynak EB; Hilleman MR; Weibel RE; Stokes J
    JAMA; 1968 Apr; 204(3):195-200. PubMed ID: 4172467
    [No Abstract]   [Full Text] [Related]  

  • 15. Production of rubella virus vaccine. Live, attenuated in canine renal cell cultures.
    Musser SJ; Hilsabeck LJ
    Am J Dis Child; 1969 Aug; 118(2):355-61. PubMed ID: 4978513
    [No Abstract]   [Full Text] [Related]  

  • 16. Live attenuated rubella virus vaccine in a private pediatric practice.
    Nickey LN; Huchton P; Rogers PL
    Tex Med; 1973 Feb; 69(2):93-8. PubMed ID: 4734589
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of antibody formation following parenteral immunization with rubella vaccine "Cendehill" and RA 27-3].
    Thomssen R
    Dtsch Med Wochenschr; 1973 Aug; 98(34):1555-9. PubMed ID: 4727387
    [No Abstract]   [Full Text] [Related]  

  • 18. Rubella vaccines.
    Dudgeon JA
    Br Med Bull; 1969 May; 25(2):159-64. PubMed ID: 4918531
    [No Abstract]   [Full Text] [Related]  

  • 19. Attenuated rubella vaccine (HPV-77): evaluation in a large controlled trial.
    Lipman RP; Bethel MB; Wooten JH; Levine RH; Pagano JS
    Am J Public Health; 1971 Jul; 61(7):1392-402. PubMed ID: 4935166
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical trial with live attenuated rubella virus vaccine (Cendehill 51 strain).
    Cherry JD; Bobinski JE; Comerci GD
    J Pediatr; 1969 Jul; 75(1):79-86. PubMed ID: 4892795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.